Johnson & Johnson's agreement with the Trump administration enables patients to access drugs at a comparable price to other ...

Aragen's new cell line development and early manufacturing platform, CHOMax, can cut timelines to approximately 10 months.

Codexis Inc. and Axolabs have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis ...

aims to advance oncology research by integrating computational design, medicinal chemistry, biology, medical science and ...

Sharp Sterile Manufacturing is investing $28 million to expand its site in Lee, Massachusetts, which offers a range of ...

Patient access to innovative new therapies requires us to reimagine the supply chain and how it integrates advanced ...

Magali Haas, MD, PhD, founded Cohen Veterans Bioscience and worked at Johnson & Johnson before becoming Psilera's new Chief ...

Eli Lilly and Company has entered a definitive agreement to acquire Ventyx Biosciences Inc., a San Diego-based clinical-stage ...

CareDx Inc. has entered a strategic collaboration with 10x Genomics to establish ImmuneScape, a multiomics research ...

AstraZeneca has named Rick R. Suarez as Senior Vice President, U.S. President and Head of the U.S. Biopharmaceuticals ...

Rentschler to manufacture VarmX’s VMX-C001 for Phase 3 development and potential commercialization.

Halozyme Therapeutics Inc. has entered into a global collaboration and exclusive license agreement with Takeda.